Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors

To assess the safety and clinical outcomes of multi-probe stereotactic radiofrequency ablation (SRFA) for very large (≥8 cm) primary and metastatic liver tumors with curative treatment intent. A retrospective, single center study carried out between 01.2005 and 06.2018. 34 consecutive patients had a...

Descripción completa

Detalles Bibliográficos
Autores principales: Schullian, Peter, Johnston, Edward W., Putzer, Daniel, Eberle, Gernot, Laimer, Gregor, Bale, Reto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994461/
https://www.ncbi.nlm.nih.gov/pubmed/32005871
http://dx.doi.org/10.1038/s41598-020-58383-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994461/
https://www.ncbi.nlm.nih.gov/pubmed/32005871
http://dx.doi.org/10.1038/s41598-020-58383-y

Ejemplares similares